Russell Investments Group
NMTR

Russell Investments Group’s 9 Meters Biopharma NMTR Stock Holding History

Russell Investments Group’s Portfolio NMTR Stock Details NMTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-1,099
Closed -$150K – 3061
2018
Q3 		$150K Buy
+1,099
New +$189K ﹤0.01% 2697

Other funds holding NMTR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
MFG
Magnus Financial Group New York $1.41B AUM 23.4% 1-Year Est. Return
California State Teachers Retirement System (CalSTRS)
California State Teachers Retirement System (CalSTRS) West Sacramento, California $94.5B AUM 29.33% 1-Year Est. Return

Russell Investments Group's NMTR Position: Q4 2018 in Review

Russell Investments Group sold out of 9 Meters Biopharma (NMTR) in Q4 2018, closing a stake of 1,099 shares — an estimated $150K sold.

Russell Investments Group first reported a position in NMTR in Q3 2018 and held it in 1 quarter. The position peaked at $150K in Q3 2018. 39 funds tracked by Wall St. Rank hold NMTR as of Q4 2018.

  • Russell Investments Group reported no remaining 9 Meters Biopharma position as of Q4 2018 after selling out during the quarter.
  • Russell Investments Group sold 1,099 9 Meters Biopharma shares in Q4 2018, an estimated $150K.
  • Russell Investments Group first reported a position in 9 Meters Biopharma in Q3 2018 and held it in 1 quarter.
  • Russell Investments Group's 9 Meters Biopharma position peaked at $150K in Q3 2018.
  • 39 funds tracked by Wall St. Rank held 9 Meters Biopharma as of Q4 2018.

Based on Russell Investments Group's 13F filing for Q4 2018, filed 11 Feb 2019.